Investment Summary
In 2025, Moderna stood as a beacon in the biotechnology sector, navigating through a landscape rife with both opportunities and challenges. This era marked a significant phase for the industry, characterized by rapid advancements in medical research, vaccine development, and therapeutic innovations. Moderna, renowned for its mRNA technology, played a crucial role in addressing global health issues, further cementing its position in the market. The year 2025, however, was not without its trials for the company and its investors. The biotech sector experienced high volatility, with Moderna witnessing a notable pullback amidst the fluctuations. These market conditions set the stage for a period defined by mixed stability and volatility, offering a unique context for investment in Moderna's stock.
How We Calculate Returns
Our calculator uses adjusted closing prices, which account for stock splits and dividend reinvestment. The total return shown represents the percentage gain from your initial investment. CAGR (Compound Annual Growth Rate) shows the smoothed annual return rate that would produce the same final value.
Important Information
Past performance is not indicative of future results. This calculator is for educational and informational purposes only and does not constitute financial advice. The calculations shown assume reinvestment of dividends where applicable and do not account for taxes, transaction fees, or inflation. Always consult a qualified financial advisor before making investment decisions.